Nicolas Villain (@nvillain_alz) 's Twitter Profile
Nicolas Villain

@nvillain_alz

Neurologue Chercheur - Neurologist Researcher #Alzheimer #Dementia #Neurodegeneration @FaculteSanteSU @Sorbonne_Univ_ @HopPitieSalpe @APHP @InstitutCerveau

ID: 1558388311605104640

linkhttps://www.researchgate.net/profile/Nicolas-Villain-2 calendar_today13-08-2022 09:42:30

2,2K Tweet

1,1K Takipçi

905 Takip Edilen

NICE (@nicecomms) 's Twitter Profile Photo

Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Benefits of slowing disease progression, by 4-6 months on average, can not justify the high cost to the NHS. Learn more: nice.org.uk/news/articles/…

Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease.

Benefits of slowing disease progression, by 4-6 months on average, can not justify the high cost to the NHS.

Learn more: nice.org.uk/news/articles/…
Nicolas Villain (@nvillain_alz) 's Twitter Profile Photo

🚨The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test🚨in my accompanying Editorial Neurology Journal as supported by the excellent & necessary collaborative study led by Eduardo Zimmer Zimmer Lab et al! Special thx to Melissa Paretsky! dx.doi.org/10.1212/WNL.00…

Jason Cohen (@memorydoc) 's Twitter Profile Photo

"The [biomarker only] guidelines were the only guidelines that did not significantly predict future cognitive decline" or dementia ➡️ Biomarkers are great but: Not perfect Not a diagnosis Not to be used in isolation, no matter what folks w conflicts of interest say

Nicholas Ashton (@nicholasashton) 's Twitter Profile Photo

🚨 Available as a preprint – The Alzheimer's Association #pTau round robin study 🚨 📣 33 different ways to measure #blood #pTau 📣 Mass Spec, semi & fully-auto immunoassays 📣 #pTau217 consistently best 📣 Corr. between assays = optimism for standardisation medrxiv.org/content/10.110…

🚨 Available as a preprint – The <a href="/alzassociation/">Alzheimer's Association</a> #pTau round robin study 🚨

📣 33 different ways to measure #blood #pTau
📣 Mass Spec, semi &amp; fully-auto immunoassays
📣 #pTau217 consistently best 
📣 Corr. between assays = optimism for standardisation 

medrxiv.org/content/10.110…
Brain (@brain1878) 's Twitter Profile Photo

Using a novel PET tracer for imaging inflammation, Appleton et al. show that people with mild cognitive impairment with onset before the age of 65 years show brain inflammation that co-localizes with tau and correlates with cognitive impairment. tinyurl.com/2v6n2nrf

Using a novel PET tracer for imaging inflammation, Appleton et al. show that people with mild cognitive impairment with onset before the age of 65 years show brain inflammation that co-localizes with tau and correlates with cognitive impairment. tinyurl.com/2v6n2nrf
Neurology Journal (@greenjournal) 's Twitter Profile Photo

This Clinical/Scientific Note reports a case of fatal super-refractory status epilepticus associated with amyloid-related imaging abnormalities (#ARIA): bit.ly/4fVZnm7 #NeuroTwitter

This Clinical/Scientific Note reports a case of fatal super-refractory status epilepticus associated with amyloid-related imaging abnormalities (#ARIA): bit.ly/4fVZnm7

#NeuroTwitter
Mathias Jucker (@mathiasjucker) 's Twitter Profile Photo

I totally agree with Simon Mead. Perhaps Alberto J Espay will attend the upcoming conference secure.qgiv.com/event/mechanis… where we will discuss such issues based on scientific data. I would be curious to listen to Alberto J Espay and be allowed to challenge his incomprehensible conclusions.

Centre de Neurologie Cognitive (@cnc_alzheimer) 's Twitter Profile Photo

Ischemic stroke associated with amyloid‐related imaging abnormalities in a patient treated with lecanemab - Gibson - Alzheimer's & Dementia - Wiley Online Library alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…